Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 1
2006 3
2007 4
2008 4
2009 3
2010 8
2011 7
2012 4
2013 5
2014 3
2015 2
2016 9
2017 10
2018 11
2019 7
2020 15
2021 17
2022 8
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

129 results

Results by year

Filters applied: . Clear all
Page 1
The paradigm change from reactive medical services to 3PM in ischemic stroke: a holistic approach utilising tear fluid multi-omics, mitochondria as a vital biosensor and AI-based multi-professional data interpretation.
Golubnitschaja O, Polivka J Jr, Potuznik P, Pesta M, Stetkarova I, Mazurakova A, Lackova L, Kubatka P, Kropp M, Thumann G, Erb C, Fröhlich H, Wang W, Baban B, Kapalla M, Shapira N, Richter K, Karabatsiakis A, Smokovski I, Schmeel LC, Gkika E, Paul F, Parini P, Polivka J. Golubnitschaja O, et al. EPMA J. 2024 Feb 27;15(1):1-23. doi: 10.1007/s13167-024-00356-6. eCollection 2024 Mar. EPMA J. 2024. PMID: 38463624 Free PMC article.
Underexplored reciprocity between genome-wide methylation status and long non-coding RNA expression reflected in breast cancer research: potential impacts for the disease management in the framework of 3P medicine.
Kapinova A, Mazurakova A, Halasova E, Dankova Z, Büsselberg D, Costigliola V, Golubnitschaja O, Kubatka P. Kapinova A, et al. Among authors: golubnitschaja o. EPMA J. 2023 May 22;14(2):249-273. doi: 10.1007/s13167-023-00323-7. eCollection 2023 Jun. EPMA J. 2023. PMID: 37275549 Free PMC article. Review.
Therapy-resistant breast cancer in focus: Clinically relevant mitigation by flavonoids targeting cancer stem cells.
Mazurakova A, Koklesova L, Vybohova D, Samec M, Kudela E, Biringer K, Šudomová M, Hassan STS, Kello M, Büsselberg D, Golubnitschaja O, Kubatka P. Mazurakova A, et al. Among authors: golubnitschaja o. Front Pharmacol. 2023 Apr 6;14:1160068. doi: 10.3389/fphar.2023.1160068. eCollection 2023. Front Pharmacol. 2023. PMID: 37089930 Free PMC article.
Phytochemical-based nanodrugs going beyond the state-of-the-art in cancer management-Targeting cancer stem cells in the framework of predictive, preventive, personalized medicine.
Koklesova L, Jakubikova J, Cholujova D, Samec M, Mazurakova A, Šudomová M, Pec M, Hassan STS, Biringer K, Büsselberg D, Hurtova T, Golubnitschaja O, Kubatka P. Koklesova L, et al. Among authors: golubnitschaja o. Front Pharmacol. 2023 Mar 23;14:1121950. doi: 10.3389/fphar.2023.1121950. eCollection 2023. Front Pharmacol. 2023. PMID: 37033601 Free PMC article. Review.
Flavonoids attenuate cancer metabolism by modulating Lipid metabolism, amino acids, ketone bodies and redox state mediated by Nrf2.
Samec M, Mazurakova A, Lucansky V, Koklesova L, Pecova R, Pec M, Golubnitschaja O, Al-Ishaq RK, Caprnda M, Gaspar L, Prosecky R, Gazdikova K, Adamek M, Büsselberg D, Kruzliak P, Kubatka P. Samec M, et al. Among authors: golubnitschaja o. Eur J Pharmacol. 2023 Jun 15;949:175655. doi: 10.1016/j.ejphar.2023.175655. Epub 2023 Mar 13. Eur J Pharmacol. 2023. PMID: 36921709 Review.
Significance of flavonoids targeting PI3K/Akt/HIF-1α signaling pathway in therapy-resistant cancer cells - A potential contribution to the predictive, preventive, and personalized medicine.
Mazurakova A, Koklesova L, Csizmár SH, Samec M, Brockmueller A, Šudomová M, Biringer K, Kudela E, Pec M, Samuel SM, Kassayova M, Hassan STS, Smejkal K, Shakibaei M, Büsselberg D, Saso L, Kubatka P, Golubnitschaja O. Mazurakova A, et al. Among authors: golubnitschaja o. J Adv Res. 2024 Jan;55:103-118. doi: 10.1016/j.jare.2023.02.015. Epub 2023 Mar 4. J Adv Res. 2024. PMID: 36871616 Free PMC article. Review.
Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications-risks and mitigation.
Kropp M, Golubnitschaja O, Mazurakova A, Koklesova L, Sargheini N, Vo TKS, de Clerck E, Polivka J Jr, Potuznik P, Polivka J, Stetkarova I, Kubatka P, Thumann G. Kropp M, et al. Among authors: golubnitschaja o. EPMA J. 2023 Feb 13;14(1):21-42. doi: 10.1007/s13167-023-00314-8. eCollection 2023 Mar. EPMA J. 2023. PMID: 36866156 Free PMC article. Review.
129 results